Immunotherapy is changing the face of cancer treatment, providing significant inroads into treating a complicated spectrum of disease. However in order to best capitalize on emerging data and develop unique approaches to broadening the benefits of treatment, there is an important need to identify cross-disciplinary synergies. In response to this need, Quantitative Immuno-Oncology—sitting at the interface between immuno-oncology and quantitative approaches from mathematics, physics, and computer science—has emerged as a field that can significantly advance our ability to interpret existing large datasets, and perform predictive analyses. This symposium will explore this promising field, covering the breadth of approaches needed to quantify interactions between tumors and the immune system, and providing a foundation from which novel immunotherapeutic strategies may be identified.
Call for Abstracts
Abstract submissions are invited for a poster session. For complete submission instructions, please send an email to QIO2017@nyas.org with the words "Abstract Information" in the subject line. Two abstracts will be selected for short talks at the symposium. The deadline for abstract submission is January 27, 2017.
|Member (Student / Postdoc / Fellow)
|Nonmember (Student / Postdoc / Fellow)
Preceding this symposium, on February 27–28, The Mushett Family Foundation, Science, Science Immunology, Science Translational Medicine, and The New York Academy of Sciences will present Frontiers in Cancer Immunotherapy. This conference will cover the latest on immunotherapeutic strategies that are currently being employed to treat some of the most devastating forms of cancer and features a keynote lecture from James P. Allison (University of Texas MD Anderson Cancer Center).
To learn more and to purchase tickets, visit www.nyas.org/Immunotherapy2017.